HQSAR studies of LSD1 allosteric inhibitors for anticancer therapy (2015)
- Autores:
- Autor USP: TROSSINI, GUSTAVO HENRIQUE GOULART - FCF
- Unidade: FCF
- Assuntos: NEOPLASIAS; ANTINEOPLÁSICOS (TERAPIA)
- Idioma: Inglês
- Imprenta:
- Editora: Sociedade Brasileira de Química - SBQ
- Local: São Paulo
- Data de publicação: 2015
- Fonte:
- Título do periódico: Resumos
- Nome do evento: Reunião Anual da Sociedade Brasileira de Química - SBQ
-
ABNT
GENESI, Giovani L e MALTAROLLO, Vinícius Gonçalves. HQSAR studies of LSD1 allosteric inhibitors for anticancer therapy. 2015, Anais.. São Paulo: Sociedade Brasileira de Química - SBQ, 2015. Disponível em: http://www.adaltech.com.br/testes/sbq2015/resumos/T1522-1.pdf. Acesso em: 19 abr. 2024. -
APA
Genesi, G. L., & Maltarollo, V. G. (2015). HQSAR studies of LSD1 allosteric inhibitors for anticancer therapy. In Resumos. São Paulo: Sociedade Brasileira de Química - SBQ. Recuperado de http://www.adaltech.com.br/testes/sbq2015/resumos/T1522-1.pdf -
NLM
Genesi GL, Maltarollo VG. HQSAR studies of LSD1 allosteric inhibitors for anticancer therapy [Internet]. Resumos. 2015 ;[citado 2024 abr. 19 ] Available from: http://www.adaltech.com.br/testes/sbq2015/resumos/T1522-1.pdf -
Vancouver
Genesi GL, Maltarollo VG. HQSAR studies of LSD1 allosteric inhibitors for anticancer therapy [Internet]. Resumos. 2015 ;[citado 2024 abr. 19 ] Available from: http://www.adaltech.com.br/testes/sbq2015/resumos/T1522-1.pdf - Synthesis of inhibitors of sirtuin 2 for chagas disease
- Synthesis, molecular modeling and docking studies of nitrofurazone analogues as trypanomicine candidates
- Molecular modeling and docking application to evaluate cruzain inhibitory activity by chalcones and hydrazides
- Building and validation of a pharmacophore model of LSD-1 inhibitors for virtual screening
- Quantitative structure-activity relationships (HQSAR, CoMFA and CoMSIA) studies for a COX-2 selective inhibitors
- Construction and validation of the CPB2.8 model and pharmacophore model design of cysteine proteases
- An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors
- Fragment- based drug discovery as alternative strategy to the drug development for neglected diseases
- Design and synthesis of sulfonylhydrazones derivatives as cruzain inhibitors
- Hologram QSAR studies of antiprotozoal activities of sesquiterpene lactones
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
